Target Market / Application Area: We promote Saxony worldwide as a top location for radiopharmacy, but also for other high-tech industries and future technologies. Saxony offers an ideal environment for investment and innovation. It is furthermore also a hotbed of the start-up and entrepreneurial scene.

Unique Selling Proposition (USP): Saxony has the entire value chain in the field of radiopharmacy locally – from tailor-made technology solutions to research, production and application to logistics and disposal. The nuclide cluster also provides fixed structures and a network from which companies can benefit immediately – whether in the search for skilled workers or in clinical trials. Plus companies can build on a historically grown knowledge of the technology in approval agencies that accelerates processes.

Current Development Stage: We are currently supporting the establishment of the nuklid cluster with our extensive industry expertise. We will also continue to support the further development of the cluster in the future – for example, when it comes to internationalisation activities or the establishment of further companies or their growth strategies and demands.

Next Strategic Milestones: We plan to market Saxony as a radiopharmaceutical location and the cluster specifically at important national and international events. In doing so, we aim to increase global visibility and thus support companies in opening up new markets and acquiring additional customers.

Key Contact Person: Barbara Weigert (Project Manager Investor Services)